Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 378

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas

Burnichon, Nelly, Rohmer, Vincent, Amar, Laurence, Herman, Philippe, Leboulleux, Sophie, Darrouzet, Vincent, Niccoli, Patricia, Gaillard, Dominique, Chabrier, Gérard, Chabolle, Frédéric, Coupier, Isabelle, Thieblot, Philippe, Lecomte, Pierre, Bertherat, Jérôme, Wion-Barbot, Nelly, Murat, Arnaud, Venisse, Annabelle, Plouin, Pierre-François, Jeunemaitre, Xavier, Gimenez-Roqueplo, Anne-Paule, for the PGL.NET network·2009·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Germline mutations in SDHx genes cause hereditary paraganglioma. OBJECTIVE: The aim of the study was to assess the indications for succinate dehydrogenase (SDH) genetic testing in a prospective study. DESIGN: A total of 445 patients with head and neck and/or thoracic-abdominal or pelvic paragangliomas were recruited over 5 yr in 20 referral centers. In addition to classical direct sequencing of the SDHB, SDHC, and SDHD genes, two methods for detecting large genomic deletions or duplications were used, quantitative multiplex PCR of short fluorescent fragments (QMPSF) and multiplex ligation-dependent probe amplification (MLPA). RESULTS: A large variety of SDH germline mutations were found by direct sequencing in 220 patients and by QMPSF and MLPA in 22 patients (9.1%): 130 in SDHD, 96 in SDHB, and 16 in SDHC. Mutation carriers were younger and more frequently had multiple or malignant paraganglioma than patients without mutations. A head and neck paraganglioma was present in 97.7% of the SDHD and 87.5% of the SDHC mutation carriers, but in only 42.7% of the SDHB carriers. A thoracic-abdominal or pelvic location was present in 63.5% of the SDHB, 16.1% of the SDHD, and in 12.5% of the SDHC mutation carriers. Multiple paragangliomas were diagnosed in 66.9% of the SDHD mutation carriers. A malignant paraganglioma was documented in 37.5% of the SDHB, 3.1% of the SDHD, and none of the SDHC mutation carriers. CONCLUSIONS: SDH genetic testing, including tests for large genomic deletions, is indicated in all patients with head and neck and/or thoracic-abdominal or pelvic paraganglioma and can be targeted according to clinical criteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2008-2504

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 378

Metadata

Authors
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D., Chabrier, G., Chabolle, F., Coupier, I., Thieblot, P., Lecomte, P., Bertherat, J., Wion-Barbot, N., Murat, A., Venisse, A., Plouin, P.-F., Jeunemaitre, X., Gimenez-Roqueplo, A.-P., & for the PGL.NET network
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-08-01
Volume
94
Issue
8
Pages
2817-2827
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1982105873
Cited by
378
References
27
FWCI
27.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas. https://app.cochat.ai/papers/10.1210/jc.2008-2504
The paper
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D., Chabrier, G., Chabolle, F., Coupier, I., Thieblot, P., Lecomte, P., Bertherat, J., Wion-Barbot, N., Murat, A., Venisse, A., Plouin, P.-F., Jeunemaitre, X., . . . for the PGL.NET network. (2009). The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-2504

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.